Lemaitre Vascular (LMAT) Other Non Operating Income (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Other Non Operating Income of -$127000.0 for Q1 2026, down 6450.0% year-over-year from $2000.0 in Q1 2025, and up 78.51% quarter-over-quarter from -$591000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Other Non Operating Income (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Other Non Operating Income for 17 consecutive years, with -$127000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 6450.0% year-over-year to -$127000.0; the TTM figure through Mar 2026 stood at -$777000.0 (down 296.21% YoY), while the FY2025 annual figure was -$648000.0, down 305.06% from the prior year.
- Other Non Operating Income rose to -$127000.0 in Q1 2026 per LMAT's latest filing, from -$591000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $406000.0 in Q4 2023 and bottomed at -$591000.0 in Q4 2025.
- Historically, Other Non Operating Income has averaged -$47470.6 across 5 years, with a median of -$40000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 3590.91% — and 2026, when it plunged 6450.0%.
- Lemaitre Vascular's Other Non Operating Income stood at $384000.0 in 2022, then grew by 5.73% to $406000.0 in 2023, then slumped by 50.0% to $203000.0 in 2024, then tumbled by 391.13% to -$591000.0 in 2025, then soared by 78.51% to -$127000.0 in 2026.
- Business Quant data shows LMAT's Other Non Operating Income at -$127000.0 in Q1 2026, -$591000.0 in Q4 2025, and -$306000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -294,000.00 |
| Mar 31, 2026 | -127,000.00 |
| Dec 31, 2025 | -591,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -78,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -189,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | -425,000.00 |
| Dec 31, 2022 | 384,000.00 |
| Sep 30, 2022 | -266,000.00 |
| Jun 30, 2022 | -403,000.00 |
| Mar 31, 2022 | -40,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -72,000.00 |